Non-melanoma skin cancer (basal-cell carcinoma)

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

Basal-cell carcinoma is curable in most cases. Local treatments like surgical excision or other skin-directed therapies usually remove the disease. Deaths from this cancer are uncommon, and the outlook has stayed favorable for decades. Sun protection lowers risk, though vaccination does not prevent it. Without recent burden data, the overall trend is best described as stable, with most cases controlled early. Research progress is marked by the recent wave of clinical trials: 62 trials have started in the past five years, including 5 phase-3 studies, and 66 are now active. That trial pipeline is the most important current milestone, reflecting continued effort to improve care for advanced or difficult tumors. Access to these therapies varies, so a favorable outlook for most does not mean everyone receives the same treatment.

Is basal-cell carcinoma usually curable?

Yes. Most basal-cell carcinomas are cured with surgical removal or other local treatments. Cure rates are often above 95 percent when caught early, though outcomes depend on tumor size, location, and access to care.

Can basal-cell carcinoma spread to other organs?

It rarely metastasizes. However, it can invade nearby skin and tissue if left untreated, which may complicate treatment. Regular skin checks help catch growths before they become difficult to manage.

Are new treatments for basal-cell carcinoma being studied?

Yes. In the past five years, 62 trials have started, including 5 phase-3 studies, and 66 trials are currently active. These studies explore better ways to treat advanced, recurrent, or hard-to-treat basal-cell carcinoma.

Can basal-cell carcinoma be prevented?

Sun protection lowers the risk, but there is no vaccine for this cancer. Avoiding ultraviolet exposure and using sunscreen can help, though some people still develop basal-cell carcinoma despite precautions.